Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPANXN5 (Sperm protein associated with the nucleus on the X chromosome N5) is part of the SPANX (Sperm protein associated with nucleus, X chromosome) gene family, which encodes small nuclear proteins classified as cancer/testis antigens (CTAs). The family, including SPANXN5, is located on the X chromosome and exhibits highly restricted expression, being normally present only in testis but aberrantly activated in various cancers such as melanoma and breast cancers[2][4][7][8]. Functionally, SPANX proteins are involved in nuclear processes including chromatin organization, RNA binding and processing, and protein translation. In tumors, expression of SPANX proteins is associated with enhanced cell proliferation, migration, invasion, and metastasis, acting through interactions with nuclear proteins such as Lamin A/C[1][8]. Their tumor-restricted expression and immunogenic properties attract interest for cancer immunotherapy, but no direct small molecule or antibody drug interactions for SPANXN5 are documented; its clinical exploitation is mainly as a biomarker or potential target for immunotherapies[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm protein associated with the nucleus on the X chromosome N5 (SPANXN5).